An Epilepsy Drug Shows Benefits of Memory Enhancing in Alzheimer’s Patients
Scientists at the Gladstone Institute have discovered a previously approved medication that treats epilepsy, to significantly reduce memory loss in patients with Alzheimer’s disease. The study involved the use of genetically modified mice to stimulate key features of Alzheimer’s disease. These mice were administered with levetiracetam and their brain deterioration reduced by 50% in just one day. Two weeks of treatment showed the scientists that the communication between neurons also improved with the treatment and several proteins essential for normal brain function also returned to normal levels. Better learning abilities and memory were also apparent when these mice were tested in a maze.
Levetiracetam is commonly prescribed for treating epilepsy. The drug works by suppressing abnormal brain activity, which is the main cause of epilepsy. Scientists tested many anti-epileptic drugs, including levetiracetam, on the mice. These scientists are now working harder to find the precise mechanism on exactly how the drug works to reduce Alzheimer’s symptoms. The beneficial effects of levetiracetam in improving mild cognitive impairment were published by scientists at John’s Hopkins University a few months ago. This news, as well as news of the drug’s effect on the genetically modified mice at Lennart Mucke gives Alzheimer’s patients much hope. However, further research is required before human trial can begin on this method of treatment. The new findings about levetiracetam were published online in the Proceedings of the National Academy of Science.
Alzheimer’s disease affects approximately 5.4 million people in America. This figure is expected to triple by 2050. Alzheimer’s is a progressive, disease that causes brain deterioration. This occurs when protein plaques develop in the brain structure leading to the death of brain cells. Alzheimer’s patients also lack a brain chemical involved in the transmitting of brain signals. This too compounds the condition and makes it worse. Memory loss, confusion, mood swings, withdrawal and the extreme inability to carry out daily tasks are common symptoms of this degenerative disease.
The Head of Marketing at Big Mountain Drugs (BMD), a reputed Canada pharmacy, was questioned on her views of this news. -Although the introduction of this medication, for the treatment of Alzheimer’s, is still a long way away, it is extremely good news for Alzheimer’s patients. There is no available, effective, medication right now, which prevents or reverses memory loss. This drug can be an excellent breakthrough for the world of Alzheimer’s medication, if it proves effective in human trials. As the medication is still a long way from being introduced into the market, Alzheimer’s patients can continue to take their Alzheimer’s medications that improve symptoms of the condition. Many Alzheimer’s medications, such as, Exelon, Namenda and Aricept, are available in the market. These drugs are available at extremely low prices at BMD-.
Big Mountain Drugs is a registered pharmacy established in British Colombia. In addition to the regular pharmacies, it operates in Canada BMD also serves a large clientele of international customers throughout the world. This pharmacy is certified by the Canadian International Pharmacy Association (CIPA), and customers of BMD can purchase their drugs with an assurance of high quality while paying extremely low prices.
Big Mountain Drugs provides a wide portfolio of branded and generic prescription as well as OTC Drugs at affordable prices via its verified Canada pharmacies. Customers can now buy Namenda online or generic Namenda 10 mg and other dosages from BMD and have it delivered worldwide to their doorstep. Big Mountain Drugs is a CIPA approved pharmacy operating from British Colombia, Canada that serves customers worldwide with its international drugstore.
For more information on Big Mountain Drugs.Com:
Name : Ms. Estella Wong
8322 130th Street, Surrey,
British Columbia, Canada, V3W 8J9